Etamsylate Causes Regression of Endometriosis Lesions in a Rat Model

In: Journal of Clinical Medical Research · 2025 · pp. 1–6 · doi:10.46889/jcmr.2025.6319 · W4416824197
Lab / animal OA: diamond CC0
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-08 ⓘ

Etamsylate administration induced regression of implanted endometrial tissues in a rat model of endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Intraperitoneal injections of etamsylate in a suitable rat model of endometriosis produced regression of implanted endometrial tissues. Our results indicate that etamsylate is a promising candidate for endometriosis treatment.

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (18)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK